Ying Xu

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Venues

CNS neuroscience & therapeutics

Journal of psychopharmacology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Fang-Fang Zhang, Hao Wang, Yan-Meng Zhou, Hai-Yang Yu, Melanie Zhang, Xian Du, Dong Wang, Feng Zhang, Ying Xu, Ji-Guo Zhang, Han-Ting Zhang
Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice. CNS neuroscience & therapeutics 28 (5) (2022)
Yirong Yuan, Linlin Zhen, Zhi Li, Wenhua Xu, Huilin Leng, Wen Xu, Victor Zheng, Victor Luria, Jianchun Pan, Yuanxiang Tao, Hanting Zhang, Shengsheng Cao, Ying Xu
trans-Resveratrol ameliorates anxiety-like behaviors and neuropathic pain in mouse model of post-traumatic stress disorder. Journal of psychopharmacology (Oxford, England) 34 (7) (2020)
Ling Chen, Suying Cui, Haiyang Yu, Gaowen Li, Na Liu, Qiang Wu, Han-Ting Zhang, James M O'Donnell, Gang Wang, Ying Xu
Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice. Journal of psychopharmacology (Oxford, England) 33 (5) (2019)
Li Liu, Jing Zheng, Xian-Feng Huang, Xia Zhu, Shu-Ming Ding, Heng-Ming Ke, James M O'Donnell, Han-Ting Zhang, Guo-Qiang Song, Ying Xu
The neuroprotective and antidepressant-like effects of Hcyb1, a novel selective PDE2 inhibitor. CNS neuroscience & therapeutics 24 (7) (2018)
Xian-Feng Huang, Wen-Tao Jiang, Li Liu, Fang-Chen Song, Xia Zhu, Gui-Lan Shi, Shu-Ming Ding, Heng-Ming Ke, Wei Wang, James M O'Donnell, Han-Ting Zhang, Hai-Bin Luo, Yi-Qian Wan, Guo-Qiang Song, Ying Xu
A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling. CNS neuroscience & therapeutics 24 (10) (2018)

Ying Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ying Xu